1,1,1-trifluoro-2-iodoethane is an organofluorine compound with the chemical formula CH₂FI₃. It's a colorless liquid with a pungent odor.
**Importance in Research:**
While it's not widely known, 1,1,1-trifluoro-2-iodoethane is a potentially interesting molecule for research due to its unique properties:
* **Fluorination:** The presence of three fluorine atoms on one carbon atom significantly affects its reactivity and properties. Fluorine is the most electronegative element, making the carbon atom electron-deficient and susceptible to nucleophilic attack.
* **Iodination:** The iodine atom makes it a good substrate for reactions involving iodine-containing reagents or radical reactions.
* **Chirality:** The molecule is chiral, meaning it exists in two enantiomeric forms (mirror images). This opens up opportunities to study stereochemistry and enantioselective reactions.
**Potential Applications:**
The combination of fluorine and iodine makes this compound potentially useful in various areas of research, including:
* **Organic Synthesis:** It can be used as a building block for the synthesis of other fluorinated compounds, which are often found in pharmaceuticals, agrochemicals, and materials science.
* **Medicinal Chemistry:** Fluorine substitution can improve the pharmacokinetic properties of drugs, such as increased metabolic stability and improved bioavailability.
* **Materials Science:** Fluorine often imparts hydrophobic and oleophobic properties to materials, making them useful in coatings, membranes, and other applications.
**Challenges and Safety:**
1,1,1-trifluoro-2-iodoethane is a relatively unexplored compound, and its synthesis and handling require careful attention to safety due to the potential for toxicity and reactivity.
**Overall:**
1,1,1-trifluoro-2-iodoethane is a promising molecule for research with potential applications in various fields. Further investigation into its synthesis, reactivity, and properties could lead to new discoveries and advancements.
1,1,1-trifluoro-2-iodoethane: structure in first source
ID Source | ID |
---|---|
PubMed CID | 67709 |
SCHEMBL ID | 30918 |
MeSH ID | M000598241 |
Synonym |
---|
2,2,2-trifluoroethyl iodide |
353-83-3 |
trifluoroethyl iodide |
1,1,1-trifluoro-2-iodoethane |
inchi=1/c2h2f3i/c3-2(4,5)1-6/h1h |
ethane, 1,1,1-trifluoro-2-iodo- |
1,1,1-trifluoro-2-iodoethane, 99% |
einecs 206-541-0 |
T1148 |
AKOS005258207 |
1,1,1-trifluoro-2-iodo-ethane |
1,1,1-trifluoroiodoethane |
unii-ca0j38we9z |
ca0j38we9z , |
1-iodo-2,2,2-trifluoroethane , |
2-iodo-1,1,1-trifluoroethane |
A822764 |
BP-12693 |
FT-0612650 |
2,2,2-trifluoroiodoethane |
2,2,2-trifluoro-1-iodoethane |
FD2058 |
SCHEMBL30918 |
J-504800 |
2-iodo-1,1,1,-trifluoroethane |
cf3ch2i |
trifluoroiodoethane |
trifluoro ethyl iodide |
iodotrifluoroethane |
2-iodo-1,1,1-trifluoro-ethane |
1,1,1-trifiuoro-2-iodoethane |
2,2,2,-trifluoroethyl iodide |
2-iodo-1,1,1 trifluoroethane |
ich2cf3 |
2,2,2-trifluoro-ethyl iodide |
2,2,2-trifluoroethyliodide |
2-iodo-1,1,1-trifluoroethaane |
1h,1h-perfluoroethyl iodide |
c2h2f3i |
DTXSID80188810 |
mfcd00001082 |
CS-D1740 |
SY001054 |
AMY25651 |
FS-4196 |
ethane,1,1,1-trifluoro-2-iodo- |
Q27275372 |
1,1,1-trifluoro-2-iodoethane trifluoroethyl iodide |
2,2,2-trifluoroethyl iodide, 2-iodo-1,1,1-trifluoroethane |
EN300-91258 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 2 (40.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (24.44) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |